Chronic ischaemic cardiomyopathy
Ischaemic cardiomyopathy is the most common cause of chronic heart failure. It is associated with several diagnostic and therapeutic challenges. They include mainly the detection of viable and ischaemic tissue amenable to improvement after revascularization. Revascularization is useful in patients with a critical mass of viable ischaemic myocardium. Provided that full revascularization is possible, percutaneous coronary intervention might be a valid alternative to surgical revascularization. Contrast-enhanced cardiac magnetic resonance is an important emerging tool to adequately detect viable myocardium. Right ventricular function and functional mitral regurgitations are important prognostic factors in ischaemic cardiomyopathy. Next to reshaping surgery, dedicated devices to restore left ventricular geometry, and stem cell therapy, are under clinical investigation.